A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome (Q28303147)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome
scientific article

    Statements

    A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    Ronald Grunstein
    0 references
    Guruswamy Sridhar
    0 references
    Tilman Dreykluft
    0 references
    René Dom
    0 references
    Eric Lainey
    0 references
    Anne Moorat
    0 references
    James Roberts
    0 references
    November 2007
    0 references
    8
    0 references
    7-8
    0 references
    742-52
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit